107, Ihyeon-ro 30beon-gil
Giheung-gu
Yongin-Si
South Korea
82 3 1260 9300
https://www.gcbiopharma.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 150
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Il-Sup Huh Ph.D. | Chairperson and Chief Executive Officer | N/A | N/A | 1954 |
Dr. Eun Chul Huh | President | N/A | N/A | N/A |
Mr. Yong-jun Hur | VP & Director | N/A | N/A | 1974 |
Mr. Yong-Jun Huh | Vice President and Director | N/A | N/A | 1974 |
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille's syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Green Cross Holdings was founded in 1967 and is headquartered in Yongin-Si, South Korea.
Green Cross Holdings Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.